RECOMBINETICS
Recombinetics is a developer of gene editing technologies to improve human health through advanced disease models and regenerative medicine. Its gene-editing technologies manipulate deoxyribonucleic acid (DNA) samples to add and activate genes to solve problems and also offer gene repair and gene editing tools that enable biomedical research, livestock productivity, animal agriculture, and livestock vertical markets to modify animal genomes accurately and efficiently.
RECOMBINETICS
Industry:
Biotechnology Genetics Health Care Life Science Medical
Founded:
2008-08-05
Address:
Eagan, Minnesota, United States
Country:
United States
Website Url:
http://www.recombinetics.com
Total Employee:
11+
Status:
Active
Contact:
+1 612 727 2000
Email Addresses:
[email protected]
Total Funding:
67.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-07 | Makana Therapeutics | Makana Therapeutics acquired by Recombinetics | N/A |
Investors List
Grant Newlin
Grant Newlin investment in Venture Round - Recombinetics
Official Site Inspections
http://www.recombinetics.com
- Host name: 202.88.225.35.bc.googleusercontent.com
- IP address: 35.225.88.202
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Recombinetics"
Recombinetics | Gene Editing Solutions | Home
Recombinetics is a recognized leader in animal gene editing and associated applied technologies for biomedical research, regenerative medicine and animal agriculture.See details»
Our Company - Recombinetics
Recombinetics is a privately-held BioVenture company focused on solving some of the world’s most intractable challenges through gene editing. Transforming …See details»
Our Team - Recombinetics
Recombinetics has strategically built our organization around three core markets—biomedical research, regenerative medicine, and a safe, abundant food supply. Our business platforms continue to progress supported by an expert …See details»
Recombinetics - Crunchbase Company Profile & Funding
Recombinetics is a developer of gene editing technologies to improve human health through advanced disease models and regenerative medicine. Its gene-editing technologies …See details»
Recombinetics - LinkedIn
Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing...See details»
Recombinetics - Overview, News & Similar companies - ZoomInfo
Jan 18, 2022 · Recombinetics contact info: Phone number: (612) 727-2000 Website: www.recombinetics.com What does Recombinetics do? Founded in 2008, Recombinetics Inc. …See details»
Recombinetics - Wikipedia
Recombinetics is a St. Paul, Minnesota-based bio-engineering company. [1] The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the …See details»
Recombinetics' Leadership Team Team - Team members and org …
The leadership team at Recombinetics has a history of research and development in the fields of animal sciences, biotechnology, and medical technology. The team has also been involved in …See details»
SCOTT FAHRENKRUG - Co-Founder at Recombinetics
Scott Fahrenkrug has an extensive work experience spanning nearly four decades. In 1982, they served as an Honor Guard, Corporal, 3rd US Infantry in the US Army. In 1997, they began working as a Molecular Biologist for the US …See details»
Recombinetics, Inc. Company Profile | Eagan, MN | Competitors ...
Find company research, competitor information, contact details & financial data for Recombinetics, Inc. of Eagan, MN. Get the latest business insights from Dun & Bradstreet.See details»
Recombinetics Inc. Merges with Makana Therapeutics …
EAGAN, Minn., Oct. 8, 2020 /PRNewswire/ -- Recombinetics Inc., a leading gene editing company with platform technology in therapeutics development, today announced that it has merged its efforts...See details»
Our Technology - Recombinetics
Through gene editing (or genome editing), Recombinetics scientists improve the genetics of animals by making precise changes to their DNA that unlock new traits. Our team of experts …See details»
Recombinetics, which engineered hornless dairy bulls, files for …
Nov 13, 2024 · Recombinetics, whose hornless dairy bulls garnered national attention for the Eagan-based gene-editing company, has filed for Chapter 11 bankruptcy after it faced a net …See details»
Recombinetics Inc. to Partner with American Preclinical Services to ...
EAGAN, Minn., Oct. 19, 2020 /PRNewswire/ -- Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today …See details»
Recombinetics Inc. Announces Neurofibromatosis Type 1 Research ...
Jan 12, 2021 · Together, AstraZeneca and Recombinetics Inc. will now undertake a study to assess selumetinib for the treatment of cutaneous neurofibromas, using Surrogen's NF1 …See details»
Recombinetics Closes $34 Million in Series A Funding
Aug 21, 2018 · Recombinetics has a global intellectual property portfolio, with 22 patents issued and more than 300 patent filings on gene-editing methods, traits, and novel reproduction …See details»
for Food Animal Health, Welfare & Sustainability - Recombinetics
Our team is working with animal breeders worldwide to help them better produce safe, abundant food by raising healthier animals in a more sustainable manner. We’re part of a team of …See details»
Therillume
Therillume is a human therapeutic company, spinning out from Recombinetics Inc., and leveraging its pioneering precise gene-editing platform and intellectual property to identify, …See details»
Recombinetics - YouTube
Since 2008, the team at Recombinetics has achieved hundreds of gene-editing breakthroughs in agriculture and biomedicine and holds more than 130 gene-editing-related patents.See details»